Authors’ Reply to Mazza et al. “Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence”

Eric J. Lenze, Angela M. Reiersen, Shelley N. Facente

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)353-354
Number of pages2
JournalDrugs
Volume82
Issue number3
DOIs
StatePublished - Feb 2022

Cite this